About this document
Dowden - Munro - 2019 - Trends in Clinical Success Rates and Therapeutic Focus by sherlisoktaviani is a document available to read on EtoBox.
The pharmaceutical industry saw a record 59 new drug approvals by the FDA in 2018, with a focus on therapeutic areas and the originators of new drugs. Success rates for late-stage development have improved, but phase II success rates remain low, with less than one in six molecules making it to market. The increasing number of drugs for orphan indications suggests a shift in focus, with smaller companies gaining traction in drug development.
- Author
- sherlisoktaviani
- Language
- EN